nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Methionine—MSRA—Irinotecan—Topotecan—ovarian cancer	0.0154	0.738	CbGdCrCtD
L-Methionine—GLUL—oviduct—ovarian cancer	0.0129	0.0241	CbGeAlD
L-Methionine—MSRA—myometrium—ovarian cancer	0.00905	0.0169	CbGeAlD
L-Methionine—MAT2B—myometrium—ovarian cancer	0.00857	0.016	CbGeAlD
L-Methionine—MSRB2—myometrium—ovarian cancer	0.00843	0.0158	CbGeAlD
L-Methionine—MSRB1—myometrium—ovarian cancer	0.00829	0.0155	CbGeAlD
L-Methionine—MAT1A—testis—ovarian cancer	0.00819	0.0153	CbGeAlD
L-Methionine—MARS—myometrium—ovarian cancer	0.00805	0.015	CbGeAlD
L-Methionine—MSRA—uterine cervix—ovarian cancer	0.00704	0.0132	CbGeAlD
L-Methionine—MSRA—decidua—ovarian cancer	0.00671	0.0125	CbGeAlD
L-Methionine—MAT2B—uterine cervix—ovarian cancer	0.00667	0.0125	CbGeAlD
L-Methionine—MSRB2—uterine cervix—ovarian cancer	0.00656	0.0123	CbGeAlD
L-Methionine—MSRB1—uterine cervix—ovarian cancer	0.00645	0.0121	CbGeAlD
L-Methionine—MARS2—vagina—ovarian cancer	0.00636	0.0119	CbGeAlD
L-Methionine—MAT2B—decidua—ovarian cancer	0.00635	0.0119	CbGeAlD
L-Methionine—MSRB2—decidua—ovarian cancer	0.00625	0.0117	CbGeAlD
L-Methionine—MSRB1—decidua—ovarian cancer	0.00615	0.0115	CbGeAlD
L-Methionine—MAT2B—endometrium—ovarian cancer	0.00603	0.0113	CbGeAlD
L-Methionine—METAP2—myometrium—ovarian cancer	0.00601	0.0112	CbGeAlD
L-Methionine—MARS—decidua—ovarian cancer	0.00596	0.0112	CbGeAlD
L-Methionine—MSRB2—endometrium—ovarian cancer	0.00593	0.0111	CbGeAlD
L-Methionine—MSRA—uterus—ovarian cancer	0.00587	0.011	CbGeAlD
L-Methionine—MSRB1—endometrium—ovarian cancer	0.00584	0.0109	CbGeAlD
L-Methionine—MAT2A—myometrium—ovarian cancer	0.00574	0.0107	CbGeAlD
L-Methionine—MARS2—testis—ovarian cancer	0.00567	0.0106	CbGeAlD
L-Methionine—MARS—endometrium—ovarian cancer	0.00566	0.0106	CbGeAlD
L-Methionine—MAT2B—uterus—ovarian cancer	0.00556	0.0104	CbGeAlD
L-Methionine—MSRB2—uterus—ovarian cancer	0.00546	0.0102	CbGeAlD
L-Methionine—MSRB1—uterus—ovarian cancer	0.00538	0.0101	CbGeAlD
L-Methionine—MSRA—female reproductive system—ovarian cancer	0.00528	0.00987	CbGeAlD
L-Methionine—MARS—gonad—ovarian cancer	0.00525	0.00982	CbGeAlD
L-Methionine—MTRR—myometrium—ovarian cancer	0.00522	0.00977	CbGeAlD
L-Methionine—MARS—uterus—ovarian cancer	0.00522	0.00976	CbGeAlD
L-Methionine—MSRA—bone marrow—ovarian cancer	0.00498	0.00931	CbGeAlD
L-Methionine—MSRB2—female reproductive system—ovarian cancer	0.00491	0.00919	CbGeAlD
L-Methionine—MSRB1—female reproductive system—ovarian cancer	0.00483	0.00904	CbGeAlD
L-Methionine—MSRA—female gonad—ovarian cancer	0.0048	0.00898	CbGeAlD
L-Methionine—MSRA—vagina—ovarian cancer	0.00477	0.00892	CbGeAlD
L-Methionine—MAT2B—bone marrow—ovarian cancer	0.00472	0.00882	CbGeAlD
L-Methionine—MARS—female reproductive system—ovarian cancer	0.00469	0.00877	CbGeAlD
L-Methionine—METAP2—uterine cervix—ovarian cancer	0.00468	0.00875	CbGeAlD
L-Methionine—MSRB2—bone marrow—ovarian cancer	0.00464	0.00867	CbGeAlD
L-Methionine—MSRB1—bone marrow—ovarian cancer	0.00456	0.00854	CbGeAlD
L-Methionine—MTR—myometrium—ovarian cancer	0.00456	0.00852	CbGeAlD
L-Methionine—MAT2B—female gonad—ovarian cancer	0.00455	0.0085	CbGeAlD
L-Methionine—MAT2B—vagina—ovarian cancer	0.00452	0.00845	CbGeAlD
L-Methionine—MSRB2—female gonad—ovarian cancer	0.00447	0.00836	CbGeAlD
L-Methionine—MAT2A—uterine cervix—ovarian cancer	0.00447	0.00835	CbGeAlD
L-Methionine—METAP2—decidua—ovarian cancer	0.00446	0.00833	CbGeAlD
L-Methionine—MSRB2—vagina—ovarian cancer	0.00444	0.00831	CbGeAlD
L-Methionine—MARS—bone marrow—ovarian cancer	0.00443	0.00828	CbGeAlD
L-Methionine—MSRB1—female gonad—ovarian cancer	0.0044	0.00823	CbGeAlD
L-Methionine—MSRB1—vagina—ovarian cancer	0.00437	0.00818	CbGeAlD
L-Methionine—MARS—female gonad—ovarian cancer	0.00427	0.00798	CbGeAlD
L-Methionine—MSRA—testis—ovarian cancer	0.00426	0.00796	CbGeAlD
L-Methionine—MAT2A—decidua—ovarian cancer	0.00425	0.00796	CbGeAlD
L-Methionine—MARS—vagina—ovarian cancer	0.00424	0.00793	CbGeAlD
L-Methionine—METAP2—endometrium—ovarian cancer	0.00423	0.00791	CbGeAlD
L-Methionine—GLUL—myometrium—ovarian cancer	0.00413	0.00772	CbGeAlD
L-Methionine—MARS2—lymph node—ovarian cancer	0.00411	0.00769	CbGeAlD
L-Methionine—MTRR—uterine cervix—ovarian cancer	0.00406	0.0076	CbGeAlD
L-Methionine—MAT2A—endometrium—ovarian cancer	0.00404	0.00755	CbGeAlD
L-Methionine—MAT2B—testis—ovarian cancer	0.00403	0.00754	CbGeAlD
L-Methionine—GLUL—embryo—ovarian cancer	0.00397	0.00742	CbGeAlD
L-Methionine—MSRB2—testis—ovarian cancer	0.00396	0.00741	CbGeAlD
L-Methionine—METAP2—gonad—ovarian cancer	0.00392	0.00734	CbGeAlD
L-Methionine—MSRB1—testis—ovarian cancer	0.0039	0.0073	CbGeAlD
L-Methionine—METAP2—uterus—ovarian cancer	0.0039	0.00729	CbGeAlD
L-Methionine—MTRR—decidua—ovarian cancer	0.00387	0.00724	CbGeAlD
L-Methionine—MARS—testis—ovarian cancer	0.00379	0.00708	CbGeAlD
L-Methionine—MAT2A—gonad—ovarian cancer	0.00375	0.00701	CbGeAlD
L-Methionine—MAT2A—uterus—ovarian cancer	0.00372	0.00696	CbGeAlD
L-Methionine—MTRR—endometrium—ovarian cancer	0.00368	0.00687	CbGeAlD
L-Methionine—MTR—uterine cervix—ovarian cancer	0.00354	0.00663	CbGeAlD
L-Methionine—METAP2—female reproductive system—ovarian cancer	0.0035	0.00655	CbGeAlD
L-Methionine—MTRR—gonad—ovarian cancer	0.00341	0.00638	CbGeAlD
L-Methionine—MTRR—uterus—ovarian cancer	0.00339	0.00633	CbGeAlD
L-Methionine—MTR—decidua—ovarian cancer	0.00338	0.00632	CbGeAlD
L-Methionine—MAT2A—female reproductive system—ovarian cancer	0.00335	0.00626	CbGeAlD
L-Methionine—METAP2—bone marrow—ovarian cancer	0.00331	0.00619	CbGeAlD
L-Methionine—GLUL—epithelium—ovarian cancer	0.00324	0.00606	CbGeAlD
L-Methionine—GLUL—uterine cervix—ovarian cancer	0.00321	0.006	CbGeAlD
L-Methionine—MTR—endometrium—ovarian cancer	0.00321	0.006	CbGeAlD
L-Methionine—METAP2—female gonad—ovarian cancer	0.00319	0.00596	CbGeAlD
L-Methionine—METAP2—vagina—ovarian cancer	0.00317	0.00593	CbGeAlD
L-Methionine—MAT2A—bone marrow—ovarian cancer	0.00316	0.00591	CbGeAlD
L-Methionine—MSRA—lymph node—ovarian cancer	0.00309	0.00577	CbGeAlD
L-Methionine—GLUL—decidua—ovarian cancer	0.00306	0.00572	CbGeAlD
L-Methionine—MTRR—female reproductive system—ovarian cancer	0.00304	0.00569	CbGeAlD
L-Methionine—MAT2A—female gonad—ovarian cancer	0.00304	0.00569	CbGeAlD
L-Methionine—MAT2A—vagina—ovarian cancer	0.00303	0.00566	CbGeAlD
L-Methionine—MTR—gonad—ovarian cancer	0.00297	0.00556	CbGeAlD
L-Methionine—MTR—uterus—ovarian cancer	0.00295	0.00552	CbGeAlD
L-Methionine—MAT2B—lymph node—ovarian cancer	0.00292	0.00546	CbGeAlD
L-Methionine—GLUL—endometrium—ovarian cancer	0.0029	0.00543	CbGeAlD
L-Methionine—MTRR—bone marrow—ovarian cancer	0.00287	0.00538	CbGeAlD
L-Methionine—MSRB2—lymph node—ovarian cancer	0.00287	0.00537	CbGeAlD
L-Methionine—METAP2—testis—ovarian cancer	0.00283	0.00529	CbGeAlD
L-Methionine—MSRB1—lymph node—ovarian cancer	0.00283	0.00529	CbGeAlD
L-Methionine—MTRR—female gonad—ovarian cancer	0.00277	0.00518	CbGeAlD
L-Methionine—MTRR—vagina—ovarian cancer	0.00275	0.00515	CbGeAlD
L-Methionine—MARS—lymph node—ovarian cancer	0.00274	0.00513	CbGeAlD
L-Methionine—MAT2A—testis—ovarian cancer	0.0027	0.00505	CbGeAlD
L-Methionine—GLUL—gonad—ovarian cancer	0.00269	0.00504	CbGeAlD
L-Methionine—GLUL—uterus—ovarian cancer	0.00268	0.005	CbGeAlD
L-Methionine—MTR—female reproductive system—ovarian cancer	0.00266	0.00497	CbGeAlD
L-Methionine—MTR—bone marrow—ovarian cancer	0.00251	0.00469	CbGeAlD
L-Methionine—SLC16A10—epithelium—ovarian cancer	0.00247	0.00462	CbGeAlD
L-Methionine—MTRR—testis—ovarian cancer	0.00246	0.0046	CbGeAlD
L-Methionine—MTR—female gonad—ovarian cancer	0.00242	0.00452	CbGeAlD
L-Methionine—GLUL—female reproductive system—ovarian cancer	0.00241	0.0045	CbGeAlD
L-Methionine—MTR—vagina—ovarian cancer	0.0024	0.00449	CbGeAlD
L-Methionine—MTHFR—female reproductive system—ovarian cancer	0.00233	0.00436	CbGeAlD
L-Methionine—GLUL—bone marrow—ovarian cancer	0.00227	0.00425	CbGeAlD
L-Methionine—GLUL—female gonad—ovarian cancer	0.00219	0.00409	CbGeAlD
L-Methionine—GLUL—vagina—ovarian cancer	0.00218	0.00407	CbGeAlD
L-Methionine—MTR—testis—ovarian cancer	0.00214	0.00401	CbGeAlD
L-Methionine—MTHFR—female gonad—ovarian cancer	0.00212	0.00397	CbGeAlD
L-Methionine—SLC16A10—gonad—ovarian cancer	0.00205	0.00384	CbGeAlD
L-Methionine—METAP2—lymph node—ovarian cancer	0.00205	0.00383	CbGeAlD
L-Methionine—MAT2A—lymph node—ovarian cancer	0.00196	0.00366	CbGeAlD
L-Methionine—GLUL—testis—ovarian cancer	0.00194	0.00363	CbGeAlD
L-Methionine—MTHFR—testis—ovarian cancer	0.00188	0.00352	CbGeAlD
L-Methionine—SLC16A10—female reproductive system—ovarian cancer	0.00183	0.00343	CbGeAlD
L-Methionine—MTRR—lymph node—ovarian cancer	0.00178	0.00333	CbGeAlD
L-Methionine—SLC16A10—vagina—ovarian cancer	0.00166	0.0031	CbGeAlD
L-Methionine—MTR—lymph node—ovarian cancer	0.00155	0.00291	CbGeAlD
L-Methionine—SLC16A10—testis—ovarian cancer	0.00148	0.00277	CbGeAlD
L-Methionine—GLUL—lymph node—ovarian cancer	0.00141	0.00263	CbGeAlD
L-Methionine—MTHFR—lymph node—ovarian cancer	0.00137	0.00255	CbGeAlD
L-Methionine—SLC16A10—lymph node—ovarian cancer	0.00107	0.00201	CbGeAlD
L-Methionine—MAT2A—Doxorubicin—Epirubicin—ovarian cancer	0.000944	0.0454	CbGdCrCtD
L-Methionine—MAT2A—Daunorubicin—Epirubicin—ovarian cancer	0.000944	0.0454	CbGdCrCtD
L-Methionine—MAT2A—Idarubicin—Epirubicin—ovarian cancer	0.000944	0.0454	CbGdCrCtD
L-Methionine—MAT2A—Daunorubicin—Doxorubicin—ovarian cancer	0.000873	0.042	CbGdCrCtD
L-Methionine—MAT2A—Idarubicin—Doxorubicin—ovarian cancer	0.000873	0.042	CbGdCrCtD
L-Methionine—MAT2A—Epirubicin—Doxorubicin—ovarian cancer	0.000873	0.042	CbGdCrCtD
L-Methionine—MAT2A—Metabolism—CYP1B1—ovarian cancer	0.000231	0.00052	CbGpPWpGaD
L-Methionine—BHMT—Metabolism—CAV1—ovarian cancer	0.000227	0.000512	CbGpPWpGaD
L-Methionine—METAP2—Disease—TERT—ovarian cancer	0.000223	0.000501	CbGpPWpGaD
L-Methionine—GLUL—Neuronal System—MAPK1—ovarian cancer	0.000222	0.0005	CbGpPWpGaD
L-Methionine—SLC16A10—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000222	0.0005	CbGpPWpGaD
L-Methionine—SLC16A10—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000214	0.000483	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—YAP1—ovarian cancer	0.000213	0.00048	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—BRIP1—ovarian cancer	0.000212	0.000478	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PPP1CC—ovarian cancer	0.000212	0.000478	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—FASN—ovarian cancer	0.000212	0.000477	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—SLC5A5—ovarian cancer	0.000208	0.000469	CbGpPWpGaD
L-Methionine—MTRR—Disease—FASN—ovarian cancer	0.000208	0.000467	CbGpPWpGaD
L-Methionine—BHMT—Metabolism—PIK3CG—ovarian cancer	0.000207	0.000466	CbGpPWpGaD
L-Methionine—MTRR—Disease—PARP1—ovarian cancer	0.000207	0.000465	CbGpPWpGaD
L-Methionine—METAP2—Disease—CAV1—ovarian cancer	0.000206	0.000463	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—PPP2R1A—ovarian cancer	0.000205	0.000461	CbGpPWpGaD
L-Methionine—MTR—Disease—XIAP—ovarian cancer	0.000204	0.000458	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—SLC2A1—ovarian cancer	0.000201	0.000453	CbGpPWpGaD
L-Methionine—MTR—Disease—SMARCA4—ovarian cancer	0.000198	0.000446	CbGpPWpGaD
L-Methionine—MTRR—Disease—SLC2A1—ovarian cancer	0.000197	0.000444	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—PPP2R1A—ovarian cancer	0.000196	0.000441	CbGpPWpGaD
L-Methionine—METAP2—Disease—IL6ST—ovarian cancer	0.000195	0.000439	CbGpPWpGaD
L-Methionine—MTR—Disease—EREG—ovarian cancer	0.000194	0.000436	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—CYP1B1—ovarian cancer	0.000193	0.000434	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—FASN—ovarian cancer	0.000192	0.000433	CbGpPWpGaD
L-Methionine—MTHFR—Disease—HDAC6—ovarian cancer	0.000192	0.000432	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—ABCB1—ovarian cancer	0.00019	0.000428	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—SLC5A5—ovarian cancer	0.000189	0.000426	CbGpPWpGaD
L-Methionine—MAT2B—Metabolism—CAV1—ovarian cancer	0.000188	0.000424	CbGpPWpGaD
L-Methionine—METAP2—Disease—APC—ovarian cancer	0.000187	0.000422	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—TYMS—ovarian cancer	0.000187	0.000421	CbGpPWpGaD
L-Methionine—MARS2—Gene Expression—MAPK3—ovarian cancer	0.000185	0.000416	CbGpPWpGaD
L-Methionine—MARS—Gene Expression—MAPK3—ovarian cancer	0.000185	0.000416	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—SLC2A1—ovarian cancer	0.000183	0.000411	CbGpPWpGaD
L-Methionine—BHMT—Metabolism—PIK3CD—ovarian cancer	0.000182	0.00041	CbGpPWpGaD
L-Methionine—MARS—Gene Expression—MYC—ovarian cancer	0.00018	0.000405	CbGpPWpGaD
L-Methionine—MARS2—Gene Expression—MYC—ovarian cancer	0.00018	0.000405	CbGpPWpGaD
L-Methionine—GLUL—Neuronal System—HRAS—ovarian cancer	0.000178	0.000402	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—CYP1B1—ovarian cancer	0.000175	0.000394	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—FASN—ovarian cancer	0.000174	0.000391	CbGpPWpGaD
L-Methionine—MTR—Metabolism—YAP1—ovarian cancer	0.000174	0.000391	CbGpPWpGaD
L-Methionine—MAT2B—Metabolism—PIK3CG—ovarian cancer	0.000172	0.000386	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—PPP2R1A—ovarian cancer	0.000171	0.000385	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—SLC5A5—ovarian cancer	0.000171	0.000385	CbGpPWpGaD
L-Methionine—MTR—Disease—FASN—ovarian cancer	0.000169	0.000381	CbGpPWpGaD
L-Methionine—SLC16A10—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000169	0.000381	CbGpPWpGaD
L-Methionine—MTR—Disease—PARP1—ovarian cancer	0.000169	0.000379	CbGpPWpGaD
L-Methionine—MTRR—Disease—PPP2R1A—ovarian cancer	0.000168	0.000378	CbGpPWpGaD
L-Methionine—MTHFR—Disease—XIAP—ovarian cancer	0.000167	0.000375	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—SLC2A1—ovarian cancer	0.000165	0.000372	CbGpPWpGaD
L-Methionine—METAP2—Disease—PIK3CD—ovarian cancer	0.000165	0.000371	CbGpPWpGaD
L-Methionine—MTHFR—Disease—SMARCA4—ovarian cancer	0.000162	0.000365	CbGpPWpGaD
L-Methionine—MTR—Disease—SLC2A1—ovarian cancer	0.000161	0.000362	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—ABCB1—ovarian cancer	0.000159	0.000358	CbGpPWpGaD
L-Methionine—BHMT—Metabolism—PIK3CB—ovarian cancer	0.000159	0.000357	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—CYP1B1—ovarian cancer	0.000158	0.000357	CbGpPWpGaD
L-Methionine—MTHFR—Disease—EREG—ovarian cancer	0.000158	0.000356	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—TYMS—ovarian cancer	0.000156	0.000351	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—TERT—ovarian cancer	0.000156	0.000351	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—PPP2R1A—ovarian cancer	0.000155	0.00035	CbGpPWpGaD
L-Methionine—MAT2B—Metabolism—PIK3CD—ovarian cancer	0.000151	0.00034	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—CAV1—ovarian cancer	0.000151	0.000339	CbGpPWpGaD
L-Methionine—METAP2—Disease—ERBB2—ovarian cancer	0.000146	0.000328	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—ABCB1—ovarian cancer	0.000144	0.000325	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—CAV1—ovarian cancer	0.000144	0.000324	CbGpPWpGaD
L-Methionine—METAP2—Disease—PIK3CB—ovarian cancer	0.000144	0.000323	CbGpPWpGaD
L-Methionine—METAP2—Disease—MTOR—ovarian cancer	0.000144	0.000323	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—YAP1—ovarian cancer	0.000142	0.00032	CbGpPWpGaD
L-Methionine—MTR—Metabolism—FASN—ovarian cancer	0.000142	0.000319	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—TYMS—ovarian cancer	0.000142	0.000319	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PPP2R1A—ovarian cancer	0.000141	0.000316	CbGpPWpGaD
L-Methionine—MTR—Metabolism—SLC5A5—ovarian cancer	0.000139	0.000314	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—ESR1—ovarian cancer	0.000139	0.000312	CbGpPWpGaD
L-Methionine—MTHFR—Disease—FASN—ovarian cancer	0.000139	0.000312	CbGpPWpGaD
L-Methionine—MTHFR—Disease—PARP1—ovarian cancer	0.000138	0.000311	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—PIK3CG—ovarian cancer	0.000137	0.000309	CbGpPWpGaD
L-Methionine—BHMT—Metabolism—PTEN—ovarian cancer	0.000137	0.000309	CbGpPWpGaD
L-Methionine—MTR—Disease—PPP2R1A—ovarian cancer	0.000137	0.000308	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—IL6ST—ovarian cancer	0.000137	0.000307	CbGpPWpGaD
L-Methionine—METAP2—Disease—CDKN1B—ovarian cancer	0.000135	0.000303	CbGpPWpGaD
L-Methionine—MTR—Metabolism—SLC2A1—ovarian cancer	0.000135	0.000303	CbGpPWpGaD
L-Methionine—MTRR—Disease—TERT—ovarian cancer	0.000133	0.0003	CbGpPWpGaD
L-Methionine—MTHFR—Disease—SLC2A1—ovarian cancer	0.000132	0.000296	CbGpPWpGaD
L-Methionine—MAT2B—Metabolism—PIK3CB—ovarian cancer	0.000132	0.000296	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—APC—ovarian cancer	0.000131	0.000295	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—PIK3CG—ovarian cancer	0.000131	0.000295	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—ABCB1—ovarian cancer	0.00013	0.000294	CbGpPWpGaD
L-Methionine—MTR—Metabolism—CYP1B1—ovarian cancer	0.000129	0.000291	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—TYMS—ovarian cancer	0.000128	0.000288	CbGpPWpGaD
L-Methionine—METAP2—Disease—CTNNB1—ovarian cancer	0.000127	0.000287	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—CAV1—ovarian cancer	0.000126	0.000283	CbGpPWpGaD
L-Methionine—MARS—Gene Expression—AKT1—ovarian cancer	0.000125	0.000281	CbGpPWpGaD
L-Methionine—MARS2—Gene Expression—AKT1—ovarian cancer	0.000125	0.000281	CbGpPWpGaD
L-Methionine—METAP2—Disease—PTEN—ovarian cancer	0.000124	0.000279	CbGpPWpGaD
L-Methionine—MTRR—Disease—CAV1—ovarian cancer	0.000123	0.000277	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—PIK3CD—ovarian cancer	0.000121	0.000271	CbGpPWpGaD
L-Methionine—MTRR—Disease—IL6ST—ovarian cancer	0.000117	0.000263	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—FASN—ovarian cancer	0.000116	0.000261	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—PIK3CD—ovarian cancer	0.000115	0.00026	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PPP2R1A—ovarian cancer	0.000115	0.000258	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—PIK3CG—ovarian cancer	0.000115	0.000258	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—CAV1—ovarian cancer	0.000114	0.000257	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—SLC5A5—ovarian cancer	0.000114	0.000257	CbGpPWpGaD
L-Methionine—MAT2B—Metabolism—PTEN—ovarian cancer	0.000114	0.000256	CbGpPWpGaD
L-Methionine—MTRR—Disease—APC—ovarian cancer	0.000112	0.000253	CbGpPWpGaD
L-Methionine—MTHFR—Disease—PPP2R1A—ovarian cancer	0.000112	0.000252	CbGpPWpGaD
L-Methionine—METAP2—Disease—STAT3—ovarian cancer	0.000111	0.00025	CbGpPWpGaD
L-Methionine—METAP2—Disease—NRAS—ovarian cancer	0.000111	0.000249	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—SLC2A1—ovarian cancer	0.00011	0.000248	CbGpPWpGaD
L-Methionine—MTR—Disease—TERT—ovarian cancer	0.000109	0.000244	CbGpPWpGaD
L-Methionine—MTR—Metabolism—ABCB1—ovarian cancer	0.000106	0.000239	CbGpPWpGaD
L-Methionine—METAP2—Disease—MAPK3—ovarian cancer	0.000106	0.000239	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—CYP1B1—ovarian cancer	0.000106	0.000238	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—PIK3CB—ovarian cancer	0.000105	0.000237	CbGpPWpGaD
L-Methionine—MTR—Metabolism—TYMS—ovarian cancer	0.000104	0.000235	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—PIK3CG—ovarian cancer	0.000104	0.000234	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—CAV1—ovarian cancer	0.000103	0.000232	CbGpPWpGaD
L-Methionine—METAP2—Disease—MYC—ovarian cancer	0.000103	0.000232	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—ERBB2—ovarian cancer	0.000102	0.000229	CbGpPWpGaD
L-Methionine—METAP2—Disease—MAPK1—ovarian cancer	0.000101	0.000227	CbGpPWpGaD
L-Methionine—METAP2—Disease—EGFR—ovarian cancer	0.000101	0.000227	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—PIK3CD—ovarian cancer	0.000101	0.000227	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—MTOR—ovarian cancer	0.000101	0.000226	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—PIK3CB—ovarian cancer	0.000101	0.000226	CbGpPWpGaD
L-Methionine—MTR—Disease—CAV1—ovarian cancer	0.000101	0.000226	CbGpPWpGaD
L-Methionine—MTRR—Disease—PIK3CD—ovarian cancer	9.87e-05	0.000222	CbGpPWpGaD
L-Methionine—BHMT—Metabolism—PIK3CA—ovarian cancer	9.68e-05	0.000218	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—CXCL8—ovarian cancer	9.67e-05	0.000218	CbGpPWpGaD
L-Methionine—METAP2—Disease—KRAS—ovarian cancer	9.53e-05	0.000214	CbGpPWpGaD
L-Methionine—MTR—Disease—IL6ST—ovarian cancer	9.53e-05	0.000214	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—CDKN1B—ovarian cancer	9.44e-05	0.000212	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PIK3CG—ovarian cancer	9.41e-05	0.000212	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PPP2R1A—ovarian cancer	9.38e-05	0.000211	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—CASP3—ovarian cancer	9.25e-05	0.000208	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—IL2—ovarian cancer	9.24e-05	0.000208	CbGpPWpGaD
L-Methionine—MTR—Disease—APC—ovarian cancer	9.16e-05	0.000206	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—PIK3CD—ovarian cancer	9.14e-05	0.000206	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—PTEN—ovarian cancer	9.09e-05	0.000204	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—CCND1—ovarian cancer	9.01e-05	0.000203	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—CTNNB1—ovarian cancer	8.92e-05	0.000201	CbGpPWpGaD
L-Methionine—MTHFR—Disease—TERT—ovarian cancer	8.89e-05	0.0002	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—PIK3CB—ovarian cancer	8.78e-05	0.000197	CbGpPWpGaD
L-Methionine—METAP2—Disease—PIK3CA—ovarian cancer	8.76e-05	0.000197	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—MMP9—ovarian cancer	8.74e-05	0.000197	CbGpPWpGaD
L-Methionine—MTRR—Disease—ERBB2—ovarian cancer	8.72e-05	0.000196	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—ABCB1—ovarian cancer	8.71e-05	0.000196	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—PTEN—ovarian cancer	8.69e-05	0.000196	CbGpPWpGaD
L-Methionine—MTRR—Disease—MTOR—ovarian cancer	8.61e-05	0.000194	CbGpPWpGaD
L-Methionine—MTRR—Disease—PIK3CB—ovarian cancer	8.61e-05	0.000194	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—TYMS—ovarian cancer	8.55e-05	0.000192	CbGpPWpGaD
L-Methionine—MTR—Metabolism—CAV1—ovarian cancer	8.42e-05	0.000189	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PIK3CD—ovarian cancer	8.27e-05	0.000186	CbGpPWpGaD
L-Methionine—MTHFR—Disease—CAV1—ovarian cancer	8.23e-05	0.000185	CbGpPWpGaD
L-Methionine—METAP2—Disease—HRAS—ovarian cancer	8.1e-05	0.000182	CbGpPWpGaD
L-Methionine—MTRR—Disease—CDKN1B—ovarian cancer	8.08e-05	0.000182	CbGpPWpGaD
L-Methionine—MTR—Disease—PIK3CD—ovarian cancer	8.05e-05	0.000181	CbGpPWpGaD
L-Methionine—MAT2B—Metabolism—PIK3CA—ovarian cancer	8.02e-05	0.00018	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—PIK3CB—ovarian cancer	7.97e-05	0.000179	CbGpPWpGaD
L-Methionine—BHMT—Metabolism—AKT1—ovarian cancer	7.91e-05	0.000178	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—VEGFA—ovarian cancer	7.85e-05	0.000177	CbGpPWpGaD
L-Methionine—MTHFR—Disease—IL6ST—ovarian cancer	7.8e-05	0.000175	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—STAT3—ovarian cancer	7.77e-05	0.000175	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—NRAS—ovarian cancer	7.76e-05	0.000174	CbGpPWpGaD
L-Methionine—METAP2—Disease—IL6—ovarian cancer	7.75e-05	0.000174	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PIK3CG—ovarian cancer	7.67e-05	0.000173	CbGpPWpGaD
L-Methionine—MTRR—Disease—CTNNB1—ovarian cancer	7.63e-05	0.000172	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—PTEN—ovarian cancer	7.58e-05	0.000171	CbGpPWpGaD
L-Methionine—MTHFR—Disease—APC—ovarian cancer	7.49e-05	0.000169	CbGpPWpGaD
L-Methionine—MTRR—Disease—PTEN—ovarian cancer	7.44e-05	0.000167	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—MAPK3—ovarian cancer	7.43e-05	0.000167	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—MYC—ovarian cancer	7.22e-05	0.000163	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PIK3CB—ovarian cancer	7.21e-05	0.000162	CbGpPWpGaD
L-Methionine—METAP2—Disease—AKT1—ovarian cancer	7.15e-05	0.000161	CbGpPWpGaD
L-Methionine—MTR—Disease—ERBB2—ovarian cancer	7.11e-05	0.00016	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—MAPK1—ovarian cancer	7.07e-05	0.000159	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—EGFR—ovarian cancer	7.07e-05	0.000159	CbGpPWpGaD
L-Methionine—MTR—Disease—MTOR—ovarian cancer	7.02e-05	0.000158	CbGpPWpGaD
L-Methionine—MTR—Disease—PIK3CB—ovarian cancer	7.02e-05	0.000158	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—CAV1—ovarian cancer	6.89e-05	0.000155	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—PTEN—ovarian cancer	6.89e-05	0.000155	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PIK3CD—ovarian cancer	6.74e-05	0.000152	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—KRAS—ovarian cancer	6.67e-05	0.00015	CbGpPWpGaD
L-Methionine—MTRR—Disease—STAT3—ovarian cancer	6.65e-05	0.00015	CbGpPWpGaD
L-Methionine—MTRR—Disease—NRAS—ovarian cancer	6.63e-05	0.000149	CbGpPWpGaD
L-Methionine—MTHFR—Disease—PIK3CD—ovarian cancer	6.59e-05	0.000148	CbGpPWpGaD
L-Methionine—MTR—Disease—CDKN1B—ovarian cancer	6.58e-05	0.000148	CbGpPWpGaD
L-Methionine—MAT2B—Metabolism—AKT1—ovarian cancer	6.55e-05	0.000147	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—PIK3CA—ovarian cancer	6.41e-05	0.000144	CbGpPWpGaD
L-Methionine—MTRR—Disease—MAPK3—ovarian cancer	6.35e-05	0.000143	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PIK3CG—ovarian cancer	6.28e-05	0.000141	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PTEN—ovarian cancer	6.23e-05	0.00014	CbGpPWpGaD
L-Methionine—MTR—Disease—CTNNB1—ovarian cancer	6.22e-05	0.00014	CbGpPWpGaD
L-Methionine—MTRR—Disease—MYC—ovarian cancer	6.18e-05	0.000139	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—PIK3CA—ovarian cancer	6.13e-05	0.000138	CbGpPWpGaD
L-Methionine—MTR—Disease—PTEN—ovarian cancer	6.06e-05	0.000136	CbGpPWpGaD
L-Methionine—MTRR—Disease—MAPK1—ovarian cancer	6.05e-05	0.000136	CbGpPWpGaD
L-Methionine—MTRR—Disease—EGFR—ovarian cancer	6.04e-05	0.000136	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—TP53—ovarian cancer	5.93e-05	0.000133	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PIK3CB—ovarian cancer	5.88e-05	0.000132	CbGpPWpGaD
L-Methionine—MTHFR—Disease—ERBB2—ovarian cancer	5.82e-05	0.000131	CbGpPWpGaD
L-Methionine—MTHFR—Disease—MTOR—ovarian cancer	5.74e-05	0.000129	CbGpPWpGaD
L-Methionine—MTHFR—Disease—PIK3CB—ovarian cancer	5.74e-05	0.000129	CbGpPWpGaD
L-Methionine—MTRR—Disease—KRAS—ovarian cancer	5.71e-05	0.000128	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—HRAS—ovarian cancer	5.67e-05	0.000128	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PIK3CD—ovarian cancer	5.52e-05	0.000124	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—IL6—ovarian cancer	5.43e-05	0.000122	CbGpPWpGaD
L-Methionine—MTR—Disease—STAT3—ovarian cancer	5.42e-05	0.000122	CbGpPWpGaD
L-Methionine—MTR—Disease—NRAS—ovarian cancer	5.41e-05	0.000122	CbGpPWpGaD
L-Methionine—MTHFR—Disease—CDKN1B—ovarian cancer	5.39e-05	0.000121	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—PIK3CA—ovarian cancer	5.35e-05	0.00012	CbGpPWpGaD
L-Methionine—MTRR—Disease—PIK3CA—ovarian cancer	5.25e-05	0.000118	CbGpPWpGaD
L-Methionine—MAT2A—Metabolism—AKT1—ovarian cancer	5.24e-05	0.000118	CbGpPWpGaD
L-Methionine—MTR—Disease—MAPK3—ovarian cancer	5.18e-05	0.000117	CbGpPWpGaD
L-Methionine—MTHFR—Disease—CTNNB1—ovarian cancer	5.09e-05	0.000115	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PTEN—ovarian cancer	5.08e-05	0.000114	CbGpPWpGaD
L-Methionine—MTR—Disease—MYC—ovarian cancer	5.04e-05	0.000113	CbGpPWpGaD
L-Methionine—METAP2—Signaling Pathways—AKT1—ovarian cancer	5.01e-05	0.000113	CbGpPWpGaD
L-Methionine—MTHFR—Disease—PTEN—ovarian cancer	4.96e-05	0.000112	CbGpPWpGaD
L-Methionine—MTR—Disease—MAPK1—ovarian cancer	4.93e-05	0.000111	CbGpPWpGaD
L-Methionine—MTR—Disease—EGFR—ovarian cancer	4.93e-05	0.000111	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—PIK3CA—ovarian cancer	4.86e-05	0.000109	CbGpPWpGaD
L-Methionine—MTRR—Disease—HRAS—ovarian cancer	4.85e-05	0.000109	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PIK3CB—ovarian cancer	4.81e-05	0.000108	CbGpPWpGaD
L-Methionine—MTR—Disease—KRAS—ovarian cancer	4.65e-05	0.000105	CbGpPWpGaD
L-Methionine—MTRR—Disease—IL6—ovarian cancer	4.65e-05	0.000105	CbGpPWpGaD
L-Methionine—MTHFR—Disease—STAT3—ovarian cancer	4.44e-05	9.98e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—NRAS—ovarian cancer	4.43e-05	9.96e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—PIK3CA—ovarian cancer	4.39e-05	9.89e-05	CbGpPWpGaD
L-Methionine—MAT1A—Metabolism—AKT1—ovarian cancer	4.37e-05	9.83e-05	CbGpPWpGaD
L-Methionine—MTRR—Disease—AKT1—ovarian cancer	4.29e-05	9.64e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—PIK3CA—ovarian cancer	4.28e-05	9.62e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—MAPK3—ovarian cancer	4.24e-05	9.54e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PTEN—ovarian cancer	4.16e-05	9.35e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—MYC—ovarian cancer	4.12e-05	9.28e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—MAPK1—ovarian cancer	4.03e-05	9.08e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—EGFR—ovarian cancer	4.03e-05	9.07e-05	CbGpPWpGaD
L-Methionine—GLUL—Metabolism—AKT1—ovarian cancer	3.97e-05	8.93e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—HRAS—ovarian cancer	3.96e-05	8.9e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—KRAS—ovarian cancer	3.81e-05	8.57e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—IL6—ovarian cancer	3.79e-05	8.52e-05	CbGpPWpGaD
L-Methionine—MTRR—Metabolism—AKT1—ovarian cancer	3.59e-05	8.08e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—PIK3CA—ovarian cancer	3.58e-05	8.06e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—PIK3CA—ovarian cancer	3.5e-05	7.88e-05	CbGpPWpGaD
L-Methionine—MTR—Disease—AKT1—ovarian cancer	3.49e-05	7.86e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—HRAS—ovarian cancer	3.24e-05	7.29e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—IL6—ovarian cancer	3.1e-05	6.97e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—PIK3CA—ovarian cancer	2.93e-05	6.6e-05	CbGpPWpGaD
L-Methionine—MTR—Metabolism—AKT1—ovarian cancer	2.93e-05	6.58e-05	CbGpPWpGaD
L-Methionine—MTHFR—Disease—AKT1—ovarian cancer	2.86e-05	6.43e-05	CbGpPWpGaD
L-Methionine—MTHFR—Metabolism—AKT1—ovarian cancer	2.39e-05	5.39e-05	CbGpPWpGaD
